During your consultation, we will determine whether or not our weight loss program is right for you
This combined approach is the true secret to long-term success with GLP-1 medications
If symptoms, lab concerns, or a known medical condition are driving the question, a clinician should help determine whether testing, primary care follow-up, or another next step is needed
In an angiographic substudy (n=274) conducted within CAMELOT, there was no significant difference between amlodipine and placebo on the change of atheroma volume in the coronary artery as assessed by intravascular ultrasound
Patients should inform their procedural and anesthesia teams if they take GLP-1 or dual incretin therapy, including Ozempic, Wegovy, Rybelsus, Trulicity, Victoza, Saxenda, Mounjaro, or Zepbound
EMSCULPT NEO FAQs Who is more suitable for an EMSculpt Neo treatment